These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20061627)

  • 1. Genome-wide scan of copy number variation in late-onset Alzheimer's disease.
    Heinzen EL; Need AC; Hayden KM; Chiba-Falek O; Roses AD; Strittmatter WJ; Burke JR; Hulette CM; Welsh-Bohmer KA; Goldstein DB
    J Alzheimers Dis; 2010; 19(1):69-77. PubMed ID: 20061627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel quantitative traits-associated susceptibility loci for APOE ε 4 non-carriers of Alzheimer's disease.
    Jiang S; Yang W; Qiu Y; Chen HZ;
    Curr Alzheimer Res; 2015; 12(3):218-27. PubMed ID: 25731621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
    Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
    Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide copy-number variation study of psychosis in Alzheimer's disease.
    Zheng X; Demirci FY; Barmada MM; Richardson GA; Lopez OL; Sweet RA; Kamboh MI; Feingold E
    Transl Psychiatry; 2015 Jun; 5(6):e574. PubMed ID: 26035058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Genome-Wide Methods for Elucidation of Candidate Copy Number Variations (CNVs) Contributing to Alzheimer's Disease Heritability.
    Szigeti K
    Methods Mol Biol; 2016; 1303():315-26. PubMed ID: 26235076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Definition of Late Onset Alzheimer's Disease and Anticipation Effect of Genome-Wide Significant Risk Variants: Pilot Study of the APOE e4 Allele.
    De Luca V; Spalletta G; Souza RP; Graff A; Bastos-Rodrigues L; Camargos Bicalho MA
    Neuropsychobiology; 2019; 77(1):8-12. PubMed ID: 30110694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transethnic genome-wide scan identifies novel Alzheimer's disease loci.
    Jun GR; Chung J; Mez J; Barber R; Beecham GW; Bennett DA; Buxbaum JD; Byrd GS; Carrasquillo MM; Crane PK; Cruchaga C; De Jager P; Ertekin-Taner N; Evans D; Fallin MD; Foroud TM; Friedland RP; Goate AM; Graff-Radford NR; Hendrie H; Hall KS; Hamilton-Nelson KL; Inzelberg R; Kamboh MI; Kauwe JSK; Kukull WA; Kunkle BW; Kuwano R; Larson EB; Logue MW; Manly JJ; Martin ER; Montine TJ; Mukherjee S; Naj A; Reiman EM; Reitz C; Sherva R; St George-Hyslop PH; Thornton T; Younkin SG; Vardarajan BN; Wang LS; Wendlund JR; Winslow AR; ; Haines J; Mayeux R; Pericak-Vance MA; Schellenberg G; Lunetta KL; Farrer LA
    Alzheimers Dement; 2017 Jul; 13(7):727-738. PubMed ID: 28183528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement receptor 1 gene (CR1) intragenic duplication and risk of Alzheimer's disease.
    Kucukkilic E; Brookes K; Barber I; Guetta-Baranes T; ; Morgan K; Hollox EJ
    Hum Genet; 2018 Apr; 137(4):305-314. PubMed ID: 29675612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease.
    Tedde A; Bagnoli S; Piaceri I; Lucenteforte E; Bessi V; Bracco L; Mugelli A; Sorbi S; Nacmias B
    Neurosci Lett; 2010 Jun; 477(3):121-3. PubMed ID: 20430066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairment.
    Lacour A; Espinosa A; Louwersheimer E; Heilmann S; Hernández I; Wolfsgruber S; Fernández V; Wagner H; Rosende-Roca M; Mauleón A; Moreno-Grau S; Vargas L; Pijnenburg YA; Koene T; Rodríguez-Gómez O; Ortega G; Ruiz S; Holstege H; Sotolongo-Grau O; Kornhuber J; Peters O; Frölich L; Hüll M; Rüther E; Wiltfang J; Scherer M; Riedel-Heller S; Alegret M; Nöthen MM; Scheltens P; Wagner M; Tárraga L; Jessen F; Boada M; Maier W; van der Flier WM; Becker T; Ramirez A; Ruiz A
    Mol Psychiatry; 2017 Jan; 22(1):153-160. PubMed ID: 26976043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease.
    Jasiecki J; Limon-Sztencel A; Żuk M; Chmara M; Cysewski D; Limon J; Wasąg B
    Sci Rep; 2019 Mar; 9(1):5223. PubMed ID: 30914707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Factors Affecting Late-Onset Alzheimer's Disease Susceptibility.
    Rezazadeh M; Khorrami A; Yeghaneh T; Talebi M; Kiani SJ; Heshmati Y; Gharesouran J
    Neuromolecular Med; 2016 Mar; 18(1):37-49. PubMed ID: 26553058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in Polish patients.
    Gaj P; Paziewska A; Bik W; Dąbrowska M; Baranowska-Bik A; Styczynska M; Chodakowska-Żebrowska M; Pfeffer-Baczuk A; Barcikowska M; Baranowska B; Ostrowski J
    J Alzheimers Dis; 2012; 32(1):157-68. PubMed ID: 22785395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls.
    Bellenguez C; Charbonnier C; Grenier-Boley B; Quenez O; Le Guennec K; Nicolas G; Chauhan G; Wallon D; Rousseau S; Richard AC; Boland A; Bourque G; Munter HM; Olaso R; Meyer V; Rollin-Sillaire A; Pasquier F; Letenneur L; Redon R; Dartigues JF; Tzourio C; Frebourg T; Lathrop M; Deleuze JF; Hannequin D; Genin E; Amouyel P; Debette S; Lambert JC; Campion D;
    Neurobiol Aging; 2017 Nov; 59():220.e1-220.e9. PubMed ID: 28789839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenomodulin variants, APOE and Alzheimer's disease in a Finnish case-control cohort.
    Tolppanen AM; Helisalmi S; Hiltunen M; Kolehmainen M; Schwab U; Pirttilä T; Pulkkinen L; Uusitupa M; Soininen H
    Neurobiol Aging; 2011 Mar; 32(3):546.e7-9. PubMed ID: 19524323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE-ε4 risk variant for Alzheimer's disease modifies the association between cognitive performance and cerebral morphology in healthy middle-aged individuals.
    Cacciaglia R; Molinuevo JL; Falcón C; Sánchez-Benavides G; Gramunt N; Brugulat-Serrat A; Esteller M; Morán S; Fauria K; Gispert JD;
    Neuroimage Clin; 2019; 23():101818. PubMed ID: 30991302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.
    Potkin SG; Guffanti G; Lakatos A; Turner JA; Kruggel F; Fallon JH; Saykin AJ; Orro A; Lupoli S; Salvi E; Weiner M; Macciardi F;
    PLoS One; 2009 Aug; 4(8):e6501. PubMed ID: 19668339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Decline in Alzheimer's Disease: Limited Clinical Utility for GWAS or Polygenic Risk Scores in a Clinical Trial Setting.
    Euesden J; Gowrisankar S; Qu AX; Jean PS; Hughes AR; Pulford DJ
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32370229
    [No Abstract]   [Full Text] [Related]  

  • 19. An Overview of Genome-Wide Association Studies in Alzheimer's Disease.
    Shen L; Jia J
    Neurosci Bull; 2016 Apr; 32(2):183-90. PubMed ID: 26810783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain APOE expression quantitative trait loci-based association study identified one susceptibility locus for Alzheimer's disease by interacting with APOE ε4.
    Zhang A; Zhao Q; Xu D; Jiang S
    Sci Rep; 2018 May; 8(1):8068. PubMed ID: 29795290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.